id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2018-N-3771-0009,FDA,FDA-2018-N-3771,Annual Status Report Information and Other Submissions for Postmarketing Requirements and Commitments: Using Forms FDA 3988 and FDA 3989; Guidance for Industry; Availability.,Notice,Notice of Availability,2023-09-15T04:00:00Z,2023,9,2023-09-15T04:00:00Z,,2023-09-15T13:29:21Z,2023-20014,0,0,0900006485fada46
FDA-2018-N-3771-0010,FDA,FDA-2018-N-3771,Annual Status Report Information and Other Submissions for Postmarketing Requirements and Commitments: Using Forms FDA 3988 and FDA 3989 Guidance for Industry,Other,Guidance,2023-09-15T04:00:00Z,2023,9,2023-09-15T04:00:00Z,,2024-11-07T00:52:18Z,,1,0,0900006485fb00fb
FDA-2018-N-3771-0008,FDA,FDA-2018-N-3771,Report on the Performance of Drug and Biologics Firms in Conducting Postmarketing Requirements and Commitments; Availability,Notice,Notice of Availability,2023-02-02T05:00:00Z,2023,2,2023-02-02T05:00:00Z,,2023-02-02T14:30:15Z,2023-02156,0,0,090000648562c144
FDA-2018-N-3771-0007,FDA,FDA-2018-N-3771,Report on the Performance of Drug and Biologics Firms in Conducting Postmarketing Requirements and Commitments; Availability,Notice,Notice of Availability,2022-04-21T04:00:00Z,2022,4,2022-04-21T04:00:00Z,,2022-04-21T13:18:27Z,2022-08499,0,0,0900006485029c13
FDA-2018-N-3771-0004,FDA,FDA-2018-N-3771,Annual Status Report Information and Other Submissions for Postmarketing Requirements and Commitments: Using Forms FDA 3988 and FDA 3989; Draft Guidance for Industry; Availability; Agency Information Collection Activities; Proposed Collection; Comment Request,Notice,Notice of Availability,2020-10-21T04:00:00Z,2020,10,2020-10-21T04:00:00Z,2020-12-22T04:59:59Z,2020-12-19T02:01:52Z,2020-23290,0,0,090000648491f0d0
FDA-2018-N-3771-0005,FDA,FDA-2018-N-3771,"Annual Status Report Information and Other Submissions for Postmarketing Requirements and Commitments: Using Forms FDA 3988 and FDA 3989
Guidance for Industry",Other,Guidance,2020-10-21T04:00:00Z,2020,10,2020-10-21T04:00:00Z,,2023-09-15T14:11:15Z,,0,0,090000648491f204
FDA-2018-N-3771-0003,FDA,FDA-2018-N-3771,"Report on the Performance of Drug and Biologics Firms in Conducting
Postmarketing Requirements and Commitments; Availability",Notice,Notice of Availability,2020-08-06T04:00:00Z,2020,8,2020-08-06T04:00:00Z,,2020-08-06T13:19:04Z,2020-17113,0,0,09000064847dd043
FDA-2018-N-3771-0002,FDA,FDA-2018-N-3771,Report on the Performance of Drug and Biologics Firms in Conducting Postmarketing Requirements and Commitments,Notice,Notice of Availability,2019-08-07T04:00:00Z,2019,8,2019-08-07T04:00:00Z,,2019-08-08T14:33:13Z,2019-16878,0,0,0900006483e066e4
FDA-2018-N-3771-0001,FDA,FDA-2018-N-3771,"Report on the Performance of Drug and Biologics Firms in Conducting
Postmarketing Requirements and Commitments; Availability",Notice,Notice of Availability,2018-11-19T05:00:00Z,2018,11,2018-11-19T05:00:00Z,,2018-11-19T14:51:02Z,2018-25128,0,0,09000064838e674f